These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33858320)

  • 1. Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease.
    Hirano S
    Mol Med; 2021 Apr; 27(1):40. PubMed ID: 33858320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
    Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
    Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study.
    Ekman U; Eriksson J; Forsgren L; Mo SJ; Riklund K; Nyberg L
    Lancet Neurol; 2012 Aug; 11(8):679-87. PubMed ID: 22742929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson's disease.
    Chen X; Zhang Y
    Neural Regen Res; 2024 Feb; 19(2):324-330. PubMed ID: 37488885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion and structural MRI as potential biomarkers in people with Parkinson's disease and cognitive impairment.
    Huang CC; Chen PH; Tsai CC; Chiang HF; Hsieh CC; Chen TL; Liao WH; Chen YL; Wang JJ
    Eur Radiol; 2024 Jan; 34(1):126-135. PubMed ID: 37572194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional brain imaging of cognitive dysfunction in Parkinson's disease.
    Hirano S; Shinotoh H; Eidelberg D
    J Neurol Neurosurg Psychiatry; 2012 Oct; 83(10):963-9. PubMed ID: 22807560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
    Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
    Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
    Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
    Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.
    Sawamoto N; Piccini P; Hotton G; Pavese N; Thielemans K; Brooks DJ
    Brain; 2008 May; 131(Pt 5):1294-302. PubMed ID: 18362097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical thinning across Parkinson's disease stages and clinical correlates.
    Wilson H; Niccolini F; Pellicano C; Politis M
    J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dopamine in the brain - lessons learned from Parkinson's disease.
    Meder D; Herz DM; Rowe JB; Lehéricy S; Siebner HR
    Neuroimage; 2019 Apr; 190():79-93. PubMed ID: 30465864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
    Kübler D; Schroll H; Buchert R; Kühn AA
    J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of White Matter Lesions in Parkinson's Disease: Voxel-based Analysis and Tract-based Spatial Statistics Analysis of Parkinson's Disease with Mild Cognitive Impairment.
    Pu W; Shen X; Huang M; Li Z; Zeng X; Wang R; Shen G; Yu H
    Curr Neurovasc Res; 2020; 17(4):480-486. PubMed ID: 32875986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging in Parkinson's disease: the role of monoamines in behavior.
    Brooks DJ; Piccini P
    Biol Psychiatry; 2006 May; 59(10):908-18. PubMed ID: 16581032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting-state functional connectivity of the striatum in early-stage Parkinson's disease: Cognitive decline and motor symptomatology.
    Manza P; Zhang S; Li CS; Leung HC
    Hum Brain Mapp; 2016 Feb; 37(2):648-62. PubMed ID: 26566885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?
    Jellinger KA
    J Neural Transm Suppl; 1999; 56():1-29. PubMed ID: 10370901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive impairment in Parkinson's disease].
    Tachibana H
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1142-9. PubMed ID: 24450147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
    Kim H; Oh M; Oh JS; Moon H; Chung SJ; Lee CS; Kim JS
    Nucl Med Commun; 2019 Dec; 40(12):1216-1223. PubMed ID: 31584466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
    Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.